How Iranian herbal medicine is marketed in US: A look at the packaging

A new report released Tuesday says the U.S. market for Iranian herbal products, as well as those produced by other Iranian companies, is growing at a rate that could exceed the $6 billion in annual sales of the United States’ leading producer of generic painkillers.

The report by the International Center for Science in the Americas (ICSA), a research institute based in Washington, D.C., and the Johns Hopkins Bloomberg School of Public Health, found that in the first half of 2017, the U:S.

produced about 5.7 billion milligrams of generic oxycodone, about 3.5 billion millibigrams for oxycodones sold by the generic drug company Johnson & Johnson, and about 1.4 billion millimix of generic acetaminophen.

The United States also produced more than 1.5 trillion millimics of generic opioids.

“There are many different companies producing different types of pharmaceutical products in the United